Key Takeaway: Lantheus held its Q2 2026 earnings conference call on August 6, 2026, at 8:00 AM EDT. The call provided insights into the company's financial performance and future outlook. Details regarding earnings and strategic initiatives were discussed during the session.
Price reaction · baseline $101.5 (2026-08-05 close) · hit pre-market · clean, no other LNTH news in the window
day 0 close · peak
-0.4%
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+48%
120-day peak, hindsight
Typical move
2%
average across 7 past catalysts
Lead asset
Perflutren Lipid microsphere
Phase 2 · Chronic Kidney Diseases
Full Press Release Details
August 6, 2026 8:00 AM EDT : Q2 2026 Lantheus Earnings Conference Call
The post Q2 2026 Lantheus Earnings Conference Call appeared first on Lantheus .